News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
683,823 Results
Type
Article (38986)
Company Profile (277)
Press Release (644560)
Section
Business (203844)
Career Advice (1987)
Deals (35357)
Drug Delivery (84)
Drug Development (80772)
Employer Resources (168)
FDA (16085)
Job Trends (14800)
News (344489)
Policy (32430)
Tag
Academia (2530)
Alliances (49048)
Alzheimer's disease (1217)
Approvals (16005)
Artificial intelligence (122)
Bankruptcy (352)
Best Places to Work (11479)
Biotechnology (196)
Breast cancer (109)
Cancer (948)
Cardiovascular disease (82)
Career advice (1657)
Cell therapy (208)
Clinical research (63959)
Collaboration (334)
Compensation (171)
COVID-19 (2522)
C-suite (82)
Data (903)
Diabetes (138)
Diagnostics (6106)
Earnings (84352)
Employer resources (146)
Events (109053)
Executive appointments (254)
FDA (16543)
Funding (298)
Gene therapy (153)
GLP-1 (562)
Government (4319)
Healthcare (18660)
Infectious disease (2600)
Inflammatory bowel disease (102)
Interviews (308)
IPO (16274)
Job creations (3623)
Job search strategy (1415)
Layoffs (409)
Legal (7848)
Lung cancer (156)
Manufacturing (157)
Medical device (13150)
Medtech (13155)
Mergers & acquisitions (19117)
Metabolic disorders (369)
Neuroscience (1459)
NextGen Class of 2024 (6497)
Non-profit (4463)
Northern California (1262)
Obesity (219)
Opinion (176)
Patents (96)
People (56149)
Phase I (19845)
Phase II (28158)
Phase III (21025)
Pipeline (254)
Postmarket research (2553)
Preclinical (8445)
Radiopharmaceuticals (234)
Rare diseases (187)
Real estate (5888)
Regulatory (21453)
Research institute (2307)
Resumes & cover letters (349)
Southern California (1128)
Startups (3561)
United States (12068)
Vaccines (539)
Weight loss (161)
Date
Today (225)
Last 7 days (918)
Last 30 days (3161)
Last 365 days (35543)
2024 (30914)
2023 (40075)
2022 (51174)
2021 (55715)
2020 (54087)
2019 (46543)
2018 (35019)
2017 (32110)
2016 (31482)
2015 (37555)
2014 (31318)
2013 (26345)
2012 (28571)
2011 (29263)
2010 (27328)
Location
Africa (713)
Arizona (187)
Asia (37032)
Australia (6039)
California (2853)
Canada (1195)
China (217)
Colorado (126)
Connecticut (126)
Europe (79307)
Florida (408)
Georgia (102)
Illinois (312)
Indiana (184)
Kansas (95)
Maryland (538)
Massachusetts (2333)
Michigan (144)
Minnesota (254)
New Jersey (851)
New York (863)
North Carolina (673)
Northern California (1262)
Ohio (129)
Pennsylvania (772)
South America (1091)
Southern California (1128)
Texas (399)
Utah (82)
Washington State (328)
683,823 Results for "indivumed inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Research Study from Indivumed Therapeutics Reveals a Path for the Discovery of New Targets and Development of Novel Cancer Therapies
September 30, 2024
·
2 min read
Indivumed Evolves into Indivumed Therapeutics to Focus on Data and AI-Driven Advancement of Precision Oncology
After twenty years as one of the first personalized oncology companies, Indivumed announced its evolution into Indivumed Therapeutics after the acquisition of Indivumed Services GmbH and its CRO service offerings by Crown Bioscience.
April 4, 2023
·
3 min read
Indivumed Services’ Hamburg Site Receives College of American Pathologists (CAP) Accreditation
Indivumed Services GmbH, a Crown Bioscience company, announced that its Hamburg site received laboratory accreditation from the College of American Pathologists.
September 11, 2023
·
3 min read
Deals
Crown Bioscience Announces Transaction Closing of Indivumed’s Service Business and Supporting Biobank
Crown Bioscience, a global contract research organization and JSR Life Sciences company, announced that it has completed its acquisition of the IndivuServ business unit of Indivumed GmbH on March 31, 2023.
April 4, 2023
·
3 min read
Deals
Crown Bioscience to Acquire Indivumed’s Service Business and Supporting Biobank
Crown Bioscience , a global contract research organization (CRO) and a JSR Life Sciences company, has announced it has entered into an agreement to acquire the IndivuServ business unit of Indivumed GmbH.
January 25, 2023
·
5 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Press Releases
Verrica Pharmaceuticals Announces Litigation Settlement with Dormer Laboratories, Inc.
Verrica Pharmaceuticals Inc. today announced the settlement of litigation with Dormer Laboratories, Inc. (“Dormer Labs”).
July 1, 2024
·
5 min read
Lophos Holdings Inc. Announces the Completion of Securities Purchase Agreement with ThreeD Capital Inc.
Lophos Holdings Inc. (CSE: MESC) (“Lophos” or the “Company”), a Canadian bioscience company focused on the cultivation and sale of Lophophora williamsii (“Peyote”) and ThreeD Capital Inc. (CSE: IDK) (OTCQB: IDKFF) (“ThreeD”), a Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, are pleased to announce the completion of its previously announced Securities Purchase Agreement (the “Agreement”).
June 20, 2024
·
4 min read
Press Releases
Virios Therapeutics, Inc. and Wex Pharmaceuticals, Inc. Announce Business Combination to Form Dogwood Therapeutics, Inc. (Nasdaq: “DWTX”)
October 8, 2024
·
14 min read
Press Releases
CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium
November 4, 2024
·
1 min read
1 of 68,383
Next